| CAS ID: | 851528-79-5 |
| Molecular Formula: | C21H23F3O5S |
| Molecular Weight: | 444.5 g/mol |
| Monoisotopic Mass: | 444.1218 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | MBX-8025 lysine | SELADELPAR LYSINE | SELADELPAR | MBX-8025 | RWJ-800025 |
| Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
| ClinicalTrial ID | NCT02609048 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Terminated |
| First Received | November 20, 2015 | Last Verified | January 29, 2018 |
| Sponsor | CymaBay Therapeutics, Inc. | ||
| PubChem: | 11236126 |
| ChEMBL: | CHEMBL230158 |